# Ethical Considerations for Clinical Investigations of Medical Products Involving Children: Draft Guidance for Industry, Sponsors, and IRBs - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/ethical-considerations-for-clinical-investigations-of-medical-products-involving-children-draft-guidance-for-industry-sponsors-and-irbs/e95b55bc-b376-4b9d-a28e-612d442be498

> FDA guidance document: Ethical Considerations for Clinical Investigations of Medical Products Involving Children: Draft Guidance for Industry, Sponsors, and IRBs. Issue date: September 26, 2022. Get complete insights and analysis.

---

## Details

- Title: Ethical Considerations for Clinical Investigations of Medical Products Involving Children: Draft Guidance for Industry, Sponsors, and IRBs
- Communication Type: Guidance Document
- Product Type: devices
- Office Name: Office of the Commissioner
- Office URL: /offices/office-of-the-commissioner/79483979-9582-427f-ac3d-46c715811424
- Issue Date: 2022-09-26
- Last Changed: 2024-04-12
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2022-D-0738">FDA-2022-D-0738</a>

## Related Documents

- [Clinical Pharmacology Considerations for Peptide Drug Products](https://www.globalkeysolutions.net/guidances/guidance-document/clinical-pharmacology-considerations-for-peptide-drug-products/1609c8ed-4d50-4235-8a00-9c63176affe8)
- [Psychedelic Drugs: Considerations for Clinical Investigations](https://www.globalkeysolutions.net/guidances/guidance-document/psychedelic-drugs-considerations-for-clinical-investigations/c22c8005-efa9-4373-893d-cf27911562b6)
- [General Clinical Pharmacology Considerations for Pediatric Studies of Drugs, Including Biological Products](https://www.globalkeysolutions.net/guidances/guidance-document/general-clinical-pharmacology-considerations-for-pediatric-studies-of-drugs-including-biological-products/764daa65-55f6-4702-b131-6e18ebf48434)